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Abstract: This work reports the use of modified reduced graphene oxide (rGO) as a platform for a 
label-free DNA-based electrochemical biosensor as a possible diagnostic tool for a DNA methylation 
assay. The biosensor sensitivity was enhanced by variously modified rGO. The rGO decorated with 
three nanoparticles (NPs)—gold (AuNPs), silver (AgNPs), and copper (CuNPs)—was implemented 
to increase the electrode surface area. Subsequently, the thiolated DNA probe (single-stranded 
DNA, ssDNA−1) was hybridized with the target DNA sequence (ssDNA-2). After the hybridization, 
the double-stranded DNA (dsDNA) was methylated by M.SssI methyltransferase (MTase) and then 
digested via a HpaII endonuclease specific site sequence of CpG (5’-CCGG-3’) islands. For 
monitoring the MTase activity, differential pulse voltammetry (DPV) was used, whereas the best 
results were obtained by rGO-AuNPs. This assay is rapid, cost-effective, sensitive, selective, highly 
specific, and displays a low limit of detection (LOD) of 0.06 U·mL−1. Lastly, this study was enriched 
with the real serum sample, where a 0.19 U·mL−1 LOD was achieved. Moreover, the developed 
biosensor offers excellent potential in future applications in clinical diagnostics, as this approach 
can be used in the design of other biosensors. 
Keywords: nanomaterials; electrochemical biosensor; DNA methylation; rGO; biomedical 
applications 
 
1. Introduction 
In the last decade, research has confirmed the crucial role of epigenetics in the origin of cancer, 
its progression, and treatment. Epigenetics play an important role in genetic expressions, which are 
not affected by changes in DNA sequences. The most significant epigenetic mechanisms are DNA 
methylation, histone modification, and gene silencing related to RNA. DNA methylation’s essential 
functions in cells occur under physiological and pathological conditions [1]. DNA methylation is a 
heritable post-translational covalent modification of DNA catalyzed by DNA methyltransferase 
(MTase). The process of methylation includes DNA MTase as the carrier of the methyl (–CH3) group 
from S-adenosyl-methionine (SAM), which is a donor to the carbon in the 5th cytosine position in the 
dinucleotide field of CpG islands. Afterwards, MTase binds the methyl group to carbon in the 
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cytosine’s 5th position to create 5-methylcytosine. The distribution of 5-methylcytosine in the genome 
is specific for each cell type and is established during embryonic development. Nonetheless, the 
methylation of DNA is not stable; it may be enhanced by de novo methylation in the cells [2,3]. 
Compared to normal cells, tumor cells have a disrupted DNA methylation pattern, either reduced 
(hypomethylation) or increased (hypermethylation) by the number of methyl groups. 
Hypomethylation usually refers to repetitive DNA sequences, such as long scattered core elements, 
while hypermethylation refers only to CpG islands. Unfortunately, the mechanism of de novo 
methylation in normal and tumor cells is not well-understood [4]. The accumulation of DNA 
methylation changes can occur within a few years before the onset of malignant growth, so these 
changes could potentially be used in the early diagnosis of cancer [5]. Several methods suitable for 
DNA methylation determination, such as polymerase chain reaction (PCR), 
electrochemiluminescence, high-performance liquid chromatography, fluorescence, and colorimetric 
methods are widely used. These methods are highly effective; however, they have some drawbacks, 
including expensive instrumentation with a need for a considerable volume of samples, false-positive 
results, several washing steps, multiple-step samples preparation procedures, and skilled operators 
[6]. By contrast, biosensors are generally sensitive devices that convert a particular physical or 
chemical signal through a transducer into a more measurable signal and contain the recognition 
element composed of biological material (bioreceptor). Biosensors do not require skilled operators, 
expensive instrumentation, or multiple-step procedures of sample preparation. DNA biosensors, 
where DNA acts as a bioreceptor, are based on hybridization to a complementary DNA sequence. 
These biosensors are composed of an immobilized single-stranded DNA (ssDNA) to detect a 
complementary DNA sequence through hybridization. This leads to the formation of double-
stranded DNA (dsDNA). DNA bioreceptors are simple, inexpensive, and widely used to detect DNA 
methylation [7]. Nevertheless, the development of innovative DNA-based biosensor strategies are 
highly desirable due to their sensitivity, low limit of detection, cost-effectiveness and specific analysis 
[8,9]. Unfortunately, in biosensor technology some obstacles must be overcome and improved, such 
as their stability and their implementation into integrated microfluidic devices [10]. 
Graphene oxide (GO) is commonly used in many scientific areas and disciplines due to its 
remarkable features. The specific surface with a large area and oxygen-rich functional groups 
supports thiolated DNA immobilization, excellent electrical conductivity, and cost-effective 
synthesis, which makes GO attractive for various electrochemical applications [11]. Reduction of GO 
is necessary for electrochemistry because the removal of oxygen-rich functional groups reinstates the 
π-conjugated system and thereby essential conductivity. The reduction of GO by Na[BH4] is strong, 
effective, and results in a similar C/O ratio as reduction by hydrazine [12]. Moreover, GO is widely 
used in biosensors fabrication due to the unique properties, such as the ratio of its surface area to 
volume, which ultimately makes the nanomaterial highly sensitive. Nevertheless, Na[BH4] reduction 
creates a material with smaller sheet resistance, making it more convenient for electrochemical 
applications [13]. The most important is nanoparticles’ ability to conduct the electrical current, which 
depends on their distribution on reduced graphene oxide (rGO). Moreover, rGO has excellent 
thermal and electrical conductivity, large surface area, and additionally exhibit flexible and inert 
properties. rGO shows significantly reduced nanotoxicity compared to graphene and GO, which 
allows its wide use in biotechnological and biomedical applications. Among others, metal 
nanoparticles (NPs) can provide the highest electrical conductivity. The integration of different 
nanomaterials in the form of a composite has attracted biosensing attention as it can bring about the 
synergic effect of nanomaterials. Moreover, using this nanomaterial can increase the sensitivity and 
stability of this assay. Therefore, the nanocomposites, including rGO-silver NPs (AuNPs), rGO-gold 
NPs (AgNPs), and rGO-copper NPs (CuNPs), were synthesized and employed in a biosensor effect 
investigation on its analytical figures of merit [14]. 
In this study, the effect of three different nanocomposites rGO-AuNPs, rGO-AgNPs, rGO-
CuNPs on the immobilization process’s stability in signal enhancement was investigated. Many 
studies used only AuNPs [15,16] for biosensors development. Besides AuNPs, there exist other 
nanoparticles, such as AgNPs and CuNPs with quite high affinity to (–SH) suitable for biosensor 
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fabrication as well. For instance, AgNPs are cheaper than gold, sufficiently stable, biocompatible, and 
can even prevent air oxidation [17]. On the other hand, CuNPs can be used as functional biological 
probes, and they can be quickly and easily prepared, with high deficiency, with almost no toxicity 
from a biological point of view and can also be intercalated into major DNA grooves [18]. The use of 
nanocomposites in biosensors fabrication has excellent potential. This is mainly due to the unique 
properties of used materials, which can replace conventional working electrodes (WEs) [19]. 
Moreover, the potential for these nanomaterials’ production exists in almost every laboratory, which 
is very desirable in producing lab-on-chips or biochips, which are expected to be used in a future 
extension of the proposed study. 
2. Materials and Methods 
2.1. Reagents 
Reagents in this publication acquired from Sigma-Aldrich (St. Louis, MO, USA) were of 
analytical grade or better quality unless otherwise stated. The specific synthetics sequences of DNA 
oligonucleotides and enzymes used in this study were adapted from [20]. Other chemicals used in 
this work, including methylene blue (MB), 1-mercapto-6-hexanol (MCH), chemicals for buffers 
preparation: sodium chloride (NaCl), magnesium chloride (MgCl2), Trizma® base, hydrochloric acid 
HCl (37%), sodium hydroxide (NaOH), potassium sulfate (K2SO4), potassium hexacyanoferrate(III) 
(K3[Fe(CN)6]), potassium hexacyanoferrate(II) (K4[Fe(CN)6]), sodium dihydrogen phosphate 
(NaH2PO4) and sodium phosphate dibasic (Na2HPO4). Reagents for the synthesis of GO and rGO-
AuNPs: 0.24 mM tetrachloroauric acid (H[AuCl4]), 37% HCl, 0.085 M sodium citrate (Na3C6H5O7), 5% 
sodium carbonate (Na2CO3), potassium permanganate (KMnO4), sodium tetrahydridoborate 
(Na[BH4]) and hydrogen peroxide (H2O2). Reagents for the of rGO-AgNPs: 10 mM solution of silver 
nitrate (AgNO3) and Na[BH4]. Reagents for synthesizing rGO-CuNPs synthesis: copper acetate 
Cu(CH3COO)2 and Na[BH4]. Moreover, this study is enriched by real human sera samples (ERM® 
Certified Reference Material, St. Louis, MO, USA). All experiments used ultrapure Milli-Q (Millipore 
System Inc., Billerica, MA, USA) water with the corresponding resistivity of 18.2 MΩ·cm. 
2.2. Apparatus  
2.2.1. Physical and Chemical Characterization 
Scanning Electron Microscopy (SEM) 
The sample was applied on a silica wafer and dried at ambient temperature (24 °C). This wafer 
was adhered to by a carbon tape to the stub, which was inserted into the scanning electron microscope 
(SEM). In this study, the SEM TESCAN MAIA 3 device (TESCAN Ltd., Brno, Czech Republic) coupled 
with a field-emission electron gun (TESCAN Ltd., Brno, Czech Republic) to investigate the 
composition and morphology of used nanocomposites. The method was adapted from a previous 
study [21] with slight modifications. 
SEM-Energy Dispersive X-ray Spectroscopy (EDX) 
In the study, SEM-energy dispersive X-ray spectroscopy (EDX) elemental mapping was 
performed for the determination of selected elements, such as C, O, Au, Ag and Cu, processed by C 
Kα1 and 2; O Kα1, Ag Lα1, Cu Lα1 and 2, and Au Mα1 edges, respectively. As a measuring device 
MIRA 2 SEM (TESCAN Ltd. Brno, Czech Republic) coupled with an EDX detector X-MAX 50 (Oxford 
instruments plc, Abingdon, UK) was used and the images were evaluated by software AZtec (Oxford 
Instruments, Abingdon, UK). An external detector SE (Everhart-Thornley, TESCAN Ltd. Brno, Czech 
Republic) was selected for image processing with an accelerating voltage 15 kV. EDX mappings of 
selected elements, such as C, O, Au, Ag and Cu were processed using C Kα1 and 2; O Kα1, Ag Lα1, 
Cu Lα1 and 2, and Au Mα1 edges, respectively. Parameters of measurements were the following: 
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working distance 15.4 mm, input energy 20,000 cts, output energy 16,000 cts with fluctuated dead 
time around 18–20%. Each analysis took place in 20 min. 
2.2.2. Electrochemical Characterization 
Electrochemical studies, including electrochemical impedance spectroscopy (EIS) and 
differential pulse voltammetry (DPV) were performed in a standard three-electrode cell, with an 
Ag/AgCl reference electrode linked by a salt bridge (50 mM PB + 0.1 M K2SO4) at constant potential 
and with Pt auxiliary electrode. A gold electrode with radius of gold disk 1.6 mm (BASi®, West 
Lafayette, IN, USA) was selected as working electrode (WE). An Autolab PGSTAT302N, in 
combination with a FRA2 potentiostat module (Metrohm, Herisau, Switzerland), was used for taking 
the electrochemical measurement. 
2.3. Methods 
2.3.1. Synthesis and Reduction of Graphene Oxide (GO) 
GO was prepared by the well-established and optimized Hummer’s method with slight 
modification [22]. 
The pH value of GO was adjusted to the value 9–10 by the addition of Na2CO3. The mixture was 
heated up to 80 °C and afterwards to it was added 800 mg of Na[BH4], which is a strong reducing 
reagent. The temperature was maintained at 80 °C for 1 h. Finally, rGO was collected and rinsed three 
times with Milli-Q water [23]. 
2.3.2. Synthesis of Nanocomposites 
Synthesis of Reduced GO (rGO)-Silver Nanoparticles (AgNPs) and rGO-Copper Nanoparticles 
(CuNPs) 
A volume of 1 mL of rGO solution (5 mg·mL–1) was added dropwise to the AgNO3 solution and 
vigorously stirred at 400 rpm. Then, 40 mg of Na[BH4] was slowly added to the mixture, and the 
final solution was stirred for 24 h to complete reduction. The final nanocomposite was rinsed three 
times with Milli-Q water, and the final volume was adjusted to 10 mL. For rGO-CuNPs synthesis, the 
AgNO3 was only replaced with Cu(CH3COO)2. 
Synthesis of rGO-Gold Nanoparticles (AuNPs) 
An amount of 3.75 mg of rGO was added to 50 mL H[AuCl4], and the mixture was sonicated for 
30 min. Subsequently, the mixture was heated up to 80 °C (stirred at 400 rpm), and 940 µL of 
Na3C6H5O7 solution was added drop by drop. The solution was sustained at 80 °C for 1 h and then 
cooled down to room temperature [24]. 
2.3.3. Working Electrode (WE) Preparation  
Following the procedure of Keighley et al. [25] the WEs were cleaned and polished with a slight 
modification. WEs were firstly sonicated in absolute ethanol and then polished with diamond 
suspension (0.5 µm) (Nanoshel LLC, Wilmington, DE, USA). Furthermore, a Piranha solution was 
prepared (75% H2SO4: 25% H2O2, equals 3:1 volume), where the electrodes were rinsed to remove all 
the organic impurities. After mechanical and chemical cleaning, WEs were cleaned electrochemically 
via cyclic voltammetry (CV) in 0.5 M H2SO4 by potential scanning between the gold reduction and 
oxidation vs. reference electrode Ag/AgCl for 50 cycles until the voltammogram was established. 
After that, the WEs were rinsed with Milli-Q water, dried in argon steam (argon 5.0, Messer Industries 
GmbH, Bad Soden, Germany), then caped and were ready to use.  
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2.3.4. rGO Immobilization, Single-Stranded DNA (ssDNA-1) Immobilization, and Hybridization 
with ssDNA-2 
In this step, WEs were prepared by dropping 5 µl of the selected nanocomposite (rGO-AuNPs, 
rGO-AgNPs, and rGO-CuNPs) on the electrode surface. Afterwards, the electrodes were dried for 30 
min under an infrared heat lamp (Beurer IL35, Ulm, Germany) with a power consumption of 150 W. 
Then, the WEs were incubated with a thiol-modified DNA probe, which has a great affinity to attach 
to the metal surface through the thiol bond with selected nanocomposites. A further step involved 
incubation with MCH solution overnight at +4 °C while the self-assembled monolayer (S-adenosyl-
methionine, SAM) was formed to block the non-specific binding, prevents clusters forming, and helps 
to anchor the target molecules. Prior to hybridization, we performed back-filling with 1 µM MCH for 
90 min. After that, the ssDNA-1 was hybridized with ssDNA-2 in the hybridization buffer [25]. 
Moreover, the probe and target were incubated at 37 °C in an oven for 1 h to provide full 
hybridization. 
2.3.5. Double-Stranded DNA (dsDNA) Methylation Process and the Digestion of dsDNA by HpaII 
Endonuclease 
The modified WEs with ssDNA-1/dsDNA-2/rGO-AuNPs; -CuNPs or -AgNPs was treated by 
various concentrations prepared from 1.6 µM stock solution of M.SssI MTase (5; 15; 25; 50; 100; 150; 
200; 300; 400; 500 U·mL−1 New England Biolabs, Ipswich, MA, USA). The modified WEs were exposed 
to the M.SssI MTase solution for 2 h at 37 °C in the oven to be methylated and then incubated in 20 
mM MB solution for 30 min at ambient temperature. After the successful methylation of the dsDNA, 
the modified WEs (ssDNA-1/dsDNA-2/rGO-AuNPs; -CuNPs or -AgNPs/M.SssI) were immersed in 
20 U·ml−1 HpaII in Tango buffer for 2 h at 37 °C in the oven. Then, the WEs were rinsed thoroughly 
with ultrapure water. 
The prepared bare and modified WEs were characterized by using EIS. The impedance spectra 
were recorded in the solution of 5 mM K4[Fe(CN)6] + 5 mM K3[Fe(CN)6] in 100 mM PB + 100 mM 
K2SO4 at pH 7.0. EIS was performed between working and auxiliary electrodes with the following 
parameters: the frequency ranges from 100 kHz to 100 mHz with an amplitude of 10 mV alternating 
current (a.c.) voltage and 250 mV direct current (d.c.) without external bias vs. reference electrode 
responds to the formal potential of the redox couple. 
2.3.6. Monitoring of M.SssI Methyltransferase (MTase) Activity 
The activity of M.SssI MTase was monitored by differential pulse voltammetry (DPV). The 
potential was swept from 0.0 V to −0.6 V, the potential amplitude was 0.025 V, and the scan-rate was 
calculated as 0.01 V·s−1. Moreover, 20 mM MB solution was used as an electrochemical probe to 
measure the quantity of 10 nM target sequences. The modified WEs were incubated for 30 min. 
3. Results and Discussion 
3.1. Biosensor Fabrication 
Figure 1 presents a simple, label-free, reliable, sensitive, and specific electrochemical DNA 
biosensor as a DNA methylation assay. In this approach, we have compared three different 
nanocomposites rGO-AuNPs, rGO-AgNPs, rGO-CuNPs, and their effect on the stability of the 
immobilization process, and the signal enhancement was investigated. The probe containing thiol 
groups (–SH) was attached to a layer from the nanomaterials, as mentioned above, by a covalent bond 
with sulfur. To ensure stability, MCH was used to create the SAM which prevents cluster forming 
and non-specific binding of DNA. Therefore, the SAM helps to improve the stability of DNA 
immobilization by proper DNA arrangement [26]. The changes in the electrochemical features of the 
interfacial electrode surface due to the modifications were characterized via EIS. The methylation 
assay is based on the DPV response, which is correlated to the amount of the intercalated MB. MB 
creates a positive charge, leading to electrostatic interactions with negatively charged phosphoric 
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acid of DNA, which allows creating π–π interactions. The transfer of electrons flow from an electrode 
to the MB, and the obtained signals indicate the quantity of methylated cytosine. 
 
 
Figure 1. Schematic of biosensor development including each step of immobilization and treatment 
by enzymes. 
3.2. Scanning Electron Microscopy (SEM) Characterization of rGO Decorated with Au, Ag and CuNPs 
The images obtained from SEM (Figure 2) display the typical morphology of the specific 
nanomaterial and declare the presence of the desired carbon nanocomposites. GO synthetized by 
modified Hummer’s method exhibited a uniform smooth microstructure with fine wrinkles. The 
reduction process of GO has resulted in a heavily wrinkled material with a preserved microstructure. 
Both materials exist in the form of large sheets. SEM images reveal the morphological characteristics 
of the prepared nanocomposites. In Figure 2A, it is evident that the layer of GO is visible and deeper 
wrinkles indicate the GO was also reduced (Figure 2B) during the synthesis of nanocomposites by 
Na[BH4]. 
 
Figure 2. Images obtained from scanning electron microscope (SEM). (A) Graphene oxide (GO) and 
(B) reduced graphene oxide (rGO) with 1 µm scale bar. 
In all nanocomposites, NPs are consistently distributed on the surface of rGO, respectively. The 
AuNPs in Figure 3C are significantly smaller than AgNPs (A) and CuNPs (B), respectively, whereas 
all of the nanocomposites are shown in 1 µm scale. AuNPs are distributed in nanometers. The 
diameter of AuNPs was 9–10 nm. On the other hand, the diameter of AgNPs was approximately 20 
nm and the size of CuNPs was approximately 70–80 nm. SEM-EDX mapping image confirmed the 
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occurrence of functional groups and the presence of expected elements that constitute NPs. All these 
nanocomposites were further characterized by FTIR technique, and obtained data are recorded in the 
Supplementary Materials (Figure S1).  
 
Figure 3. SEM images of nanocomposites of rGO decorated with the different metal nanoparticles. 
(A) silver nanoparticles (AgNPs), (B) copper nanoparticles (CuNPs), and (C) gold nanoparticles 
(AuNPs). Below are shown SEM-energy dispersive X-ray spectroscopy (EDX) images from the 
elemental mapping of demanded nanocomposites. 
3.3. Electrochemical Studies of Used Nanocomposites as Modification by Electrochemical Impedance 
Spectroscopy (EIS) 
EIS was used to characterize the successful modification and treatment of the WEs surface. As 
shown in Figure 4, the impedance spectra are composed of two parts, a semi-portion and a straight 
line. The semi-portion diameter is a demonstration of the charge transfer resistance, while the straight 
line represents the Warburg impedance, which is dominant at low frequencies due to diffusion 
processes [27]. Figure 4 shows the differences between each step of electrode surface modification for 
the three nanocomposites (rGO-AuNPs, rGO-AgNPs, and rGO-CuNPs). The bare working electrode 
has shown only a small semicircle signal in every record due to the free-electron transfer process. The 
equivalent circuit (Figure 4D) describing the system’s behavior and the measured data are 
interpolated by the curve described by the equation corresponding to the stated circuit model. 
The immobilization of rGO-AuNPs with ssDNA-1 increased charge transfer resistance due to 
electron transfer from the electrode surface. The hybridization of ssDNA-1 with the target DNA 
further increased the charge transfer resistance. Considering that the utilized electrochemical 
[Fe(CN)6]3−/4− redox pair has a negative charge, the presence of DNA, which is also negatively charged, 
results in electrostatic repulsion. Hence, the increase of resistance in charge transfer directly after 
immobilization of the probe and the target DNA is understandable. After treating dsDNA with 
M.SssI Mtase that causes the methylation, the charge transfer resistance increased again. Increased 
steric hindrance can be caused by limiting the electrochemical probe’s access to the electrode surface. 
The addition of HpaII causes dsDNA cleavage in a specific site, and consequently both the steric 
hindrance and the extent of the electrostatic repulsion decrease. Thus, the sensitivity of the developed 
biosensor depends on the difference in impedance magnitude in the process of probe immobilization 
and hybridization with target DNA where rGO-AuNPs show the highest difference because of better 
affinity –SH groups of ssDNA-1. In addition, modification with M. SssI and Hpall causes high 
impedance in rGO-AuNPs composite indicates better sensitivity. 
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Figure 4. Electrochemical impedance spectroscopy (EIS) characterization of the electrodes prepared 
by different nanocomposites, where the Nyquist plot was recorded. (A) rGO-AgNPs, (B) rGO-CuNPs, 
(C) rGO-AuNPs and its (D) equivalent circuit. 
3.4. Monitoring of Methyltransferase Activity by Differential Pulse Voltammetry (DPV) 
As can be seen in Figure 5A, the peak height increases with concentration magnification of M. 
SssI Mtase concentration. This can be attributed to the higher amount of methylation on cytosine. 
Figure 5B shows the good linear correlation between the M.SssI concentration and peak current 
amplitude observed in a broad linear-dynamic range of 5–500 U·mL−1. For more reliable results there 
are displayed two calibration curves in Figure 5B. The equation for the M.SssI in concentration range 
5–25 U·mL−1 is: I (µA) = 0.0024c (U·mL−1) + 0.029 with the correlation coefficient (R2 = 0.9954). The 
lower limit of detection (LOD) was estimated to be 0.04 U·mL−1, and the limit of quantification (LOQ) 
was 0.13 U·mL−1, calculated based on 3σ/k and 10σ/k, respectively. In this equation where σ presents 
the relative standard deviation (RSD%) obtained from three measurements of 500 U·mL−1 
concentration of M.SssI MTase and k is the calibration curve slope. On the other hand, the remaining 
concentrations (50–500 U·mL−1) employ the equation: I (µA) = 0.0004c (U·mL−1) + 0.0984 with the 
correlation coefficient (R2 = 0.99647). The LOD was calculated to be 0.06 U·mL−1, and LOQ was 0.19 
U·mL−1. In the case of ssDNA-1/dsDNA-2/rGO-AgNPs the linear equation was I (µA) = 0. 0004c 
(U·mL−1) + 0.0995 with R2 = 0.9698. The same series of measurements was performed with ssDNA-
1/dsDNA-2/rGO-CuNPs, where the equation of concentration dependence of the peak current was I 
(µA) = 0.0003c (U·mL−1) + 0.0812 (R2 =0.9895). Based on the results obtained, ssDNA-1/dsDNA-2/rGO-
AuNPs shows better sensitivity in both EIS and DPV measurements. 
 
Figure 5. Monitoring of methyltransferase activity by differential pulse voltammetry (DPV). (A) The 
voltammograms of the modified WEs by ssDNA-1/dsDNA-2/rGO-AuNPs were then methylated by 
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various concentrations of M.SssI Mtase. (B) The calibration curve showing the correlation between an 
electrochemical current response and concentration of M.SssI MTase. The error bars are represented 
using the relative standard deviation (RSD) of measurements (n = 3). 
Nowadays, several studies aimed at a DNA methylation assay have been performed by many 
scientific groups. Table 1 summarizes the nanocomposites platforms, target enzymes or labels and 
the LODs used in numerous scientific works. The table is also enriched with the results of our DNA 
methylation assay. 
Table 1. Various study comparison in dependence of limit of detection (LOD) and nanocomposite 
platform used in the case of DNA methylation assays. 
Nanocomposite 
Platform 
Target Enzyme/Label Technique 
Linear Range 
[U·mL−1] 
LOD 
[U·mL−1] 
Reference 
AuNPs 
electrodeposition 
M.SssI MTase DPV  0.50–400 0.04 [20] 
DNA-AuNPs Dam MTase DPV 0.08–30 0.20 [28] 
AuNPs 
electrodeposition 
M.SssI MTase/FcA 1 DPV  0.50–400 0.10 [29] 
AuNPs 
electrodeposition 
T.aqI MTase DPV  0.10–100  0.03 [30] 
- Dam MTase/MB DPV 0.10–50 0.07 [31] 
AuNPs 
electrodeposition 
M.SssI MTase/ HRP-
IgG 2 
DPV 0.05–80  0.10 [32] 
- Dam MTase/ RuHex 3 DPV 0.25–10 0.18 [33] 
AuNPs 
electrodeposition 
M.SssI MTase DPV 0.50–550  0.05 [34] 
rGO-AuNPs M.SssI MTase DPV 50–500 0.06 This work 
1 FcA—Ferrocenecarboxylic acid; 2 HRP-IgG—Horseradishperoxidase linked to secondary antibody; 3 
RuHex—Hexaammineruthenium(III) chloride. 
3.5. Demonstration of DNA Methylation Effect in Physiological Sera Samples 
Commercial human serum samples were used for real sample analysis (Figure 6). The undiluted 
serum samples were injected with different concentrations of the M.SssI MTase (Figure 6A). Then, a 
fabricated biosensor was utilized for monitoring the DNA methylation. As shown in Figure 6B, linear 
correlation can be observed between the resulting peak current and the desired concentration (I (µA) 
= 0.002c (U·mL−1) + 0.0263, R2 = 0.9934) in a concentration range of the M.SssI from 5 to 25 U·mL−1. The 
LOD for 50 to 500 U·mL−1 concentration was calculated to be 0.04 U·mL−1, and the LOQ was 0.14 
U·mL−1. In a 50–500 U·mL−1 concentration range of the M.SssI was obtained calibration equitation I 
(µA) = 0.0003c (U·mL−1) + 0.082 with R2 = 0.9959. The LOD was evaluated to be 0.07 U·mL−1, and the 
LOQ was 0.21 U·mL−1. The calculation was based on 3σ/k where σ presents the RSD% of three 
measurements of the 500 U·mL−1 same concentration M.SssI MTase, and k is the slope of the 
calibration curve. The obtained results indicate the applicability of the developed biosensor in 
complex physiological matrices. 
 
Figure 6. Analysis of methyltransferase activity by DPV in undiluted serum samples. (A) The 
voltammograms of the modified WEs by ssDNA−1/dsDNA-2/rGO-AuNPs were then methylated by 
various concentrations of M.SssI Mtase. (B) The calibration curve showing the correlation between an 
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electrochemical current response and concentration of M.SssI MTase. The error bars are represented 
using the RSD% of measurements (n = 3). 
3.6. Reproducibility, Repeatability and Stability Studies of the Fabricated Biosensor 
Reproducibility, stability, and selectivity studies are an important part of assay methods. The 
assay’s repeatability was investigated by plotting three independent calibration curves by the same 
modified electrodes with rGO-AuNPs and calculating the RSD% of the slopes. The calculated RSD% 
= 4.35 shows good repeatability. This indicates that our approach can be used as an effective M.SssI 
MTase activity assay. 
On the other hand, the biosensor’s reproducibility was studied by analysis of a solution of 20 
U·mL−1 of HpaII with nine freshly prepared biosensors and then the RSD% was calculated to be 4.78 
that confirms good reproducibility of the biosensor. This may stem from the stability of the complex 
between the rGO-AuNPs composite and the biological compounds. 
As a last step the stability of the developed biosensor was investigated as well. The freshly 
fabricated biosensor was placed in the refrigerator for 7 days at 4 °C and applied for the analysis of 
the same concentration of DNA MTase, and 93.42% of the initial current response was obtained. This 
result has confirmed very good stability of the developed biosensor. The biosensor can be stored for 
a relatively long time without significantly affecting the accuracy of the measurement and it is 
capable of efficient and reliable analysis over time. 
4. Conclusions 
In conclusion, a simple, sensitive, and reliable electrochemical biosensor for methylated DNA 
determination and methyltransferase activity was developed. Three different nanocomposites, 
namely, rGO-AuNPs, rGO-AgNPs, rGO-CuNPs were synthesized, characterized, and applied in the 
sensor’s construction. The best results in terms of sensitivity were obtained with rGO-AuNPs, which 
could be due to the high electrical conductivity of AuNPs. Furthermore, the AuNPs offer a good 
substrate for immobilization of the DNA, which further results in better stability and, consequently, 
sensitivity of the developed biosensor. This material was the most suitable for the DNA methylation 
assay due to the broad linear range of M.SssI concentration (50–500 U·mL−1). The biosensor developed 
with rGO-AuNPs showed good LOD (0.06 U·mL−1) and LOQ (0.19 U·mL−1). The LOD (0.04 U·mL−1) 
and LOQ (0.13 U·mL−1) values calculated from the M.SssI (5–25 U·mL−1) concentration range indicate 
that very low concentrations can be reliably detected. 
In comparison with other studies in Table 1, this material is appropriate for biosensor 
fabrication. In the case of analysis in human serum samples, it has been shown that even in the 
biological matrix, the biosensor can achieve 0.07 U·mL−1 LOD and LOQ of 0.21 U·mL−1, which is 
almost identical to the use in analysis in a buffer. The validation of the developed biosensor confirmed 
its accuracy and precision. Therefore, the developed biosensor offers an alternative that can be 
utilized in clinical analysis for preliminary measurement. 
Supplementary Materials: The following are available online at www.mdpi.com/1996-1944/13/21/4936/s1, 
Figure S1: Fourier transform infrared (FTIR) spectra of GO (black) and prepared nanocomposites: rGO (red), 
rGO-CuNPs (green), rGO-AuNPs (blue) and rGO-AgNPs (orange).  
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